What is the recommended metoprolol dose for treating tachycardia in an adult without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metoprolol Dosing for Tachycardia

For acute tachycardia in adults without contraindications, administer metoprolol 5 mg IV over 1-2 minutes, repeated every 5 minutes as needed up to a maximum total dose of 15 mg, followed by oral metoprolol 25-100 mg twice daily for maintenance. 1

Acute IV Dosing Protocol

The standard acute regimen is 5 mg IV boluses administered over 1-2 minutes, repeated every 5 minutes as tolerated, up to 3 doses (15 mg total). 1 This approach provides rapid rate control while allowing assessment of hemodynamic tolerance between doses.

  • Monitor blood pressure, heart rate, and ECG continuously during IV administration 2
  • Titrate dosing to heart rate and blood pressure response 3
  • The onset of action occurs within 5 minutes of IV administration 4, 1

Specific Indications for IV Metoprolol

Metoprolol is Class I recommended (highest level) for:

  • Stable narrow-complex tachycardias unresponsive to adenosine or vagal maneuvers 1
  • Rate control in atrial fibrillation or atrial flutter with rapid ventricular response 4, 1
  • Refractory hypertension or ongoing ischemia in STEMI patients without contraindications 3

The drug is particularly effective for supraventricular tachyarrhythmias, with studies showing ventricular rate reduction from 134 to 106 beats/min within 10 minutes in 81% of patients. 5

Absolute Contraindications (Must Exclude Before Use)

Do not administer metoprolol if any of the following are present:

  • Signs of heart failure or low output state 3, 1
  • Increased risk for cardiogenic shock (age >70 years, systolic BP <120 mmHg, sinus tachycardia >110 bpm or HR <60 bpm) 3
  • PR interval >0.24 seconds, second- or third-degree heart block 3, 2
  • Heart rate <45 beats/min 2
  • Systolic blood pressure <100 mmHg 3, 2
  • Active asthma or reactive airways disease 3, 1
  • Pre-excited atrial fibrillation or flutter (WPW syndrome) 1

Transition to Oral Therapy

After successful IV rate control, transition to oral metoprolol tartrate 25-50 mg every 6-12 hours, starting 15 minutes after the last IV dose. 3, 2

  • Over 2-3 days, transition to twice-daily dosing of metoprolol tartrate or once-daily metoprolol succinate 3
  • Titrate to a target daily dose of 200 mg as tolerated 3
  • For chronic maintenance in atrial fibrillation, use 25-100 mg twice daily orally 4

Clinical Context: Metoprolol vs. Other Beta-Blockers

Metoprolol is β1-selective, making it safer than non-selective agents (propranolol) in patients with borderline pulmonary disease. 1 However, recent evidence suggests propranolol may be superior for certain ventricular arrhythmias—specifically, propranolol reduced arrhythmic events 2.67-fold compared to metoprolol in electrical storm patients (90% vs 53.3% arrhythmia-free at 24 hours, p=0.03). 6 For standard supraventricular tachycardias and atrial fibrillation, metoprolol remains the preferred β1-selective option. 1

Common Pitfalls to Avoid

  • Hypotension is the most frequent adverse effect (occurring in approximately 31% of patients), but is usually transient and manageable 5
  • Avoid in multifocal atrial tachycardia (MAT) with severe pulmonary disease unless hypoxia and acidosis are first corrected; however, metoprolol has been used successfully in MAT after stabilization 7, 8
  • Do not use in pre-excited atrial fibrillation—metoprolol can paradoxically accelerate ventricular response via the accessory pathway 1
  • Administer IV doses slowly over the full 1-2 minute period to minimize abrupt hemodynamic changes 1

Special Populations

  • Elderly patients: Initiate at low doses with cautious titration due to decreased hepatic/renal function 2
  • Hepatic impairment: Blood levels increase substantially; start low and titrate slowly 2
  • Renal impairment: No dose adjustment required 2

References

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.